EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma

Hongze Li iD, Jiaqi Zhang, Yixiao Zhang, Zixuan Li, Yuxi Han, Yu Lun iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Hongze Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Phagocytosis, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efferocytosis plays a crucial role in maintaining the stability of the immune microenvironment. Increasing research indicates that efferocytosis core genes (ECGs) are not only widely expressed in immune cells, but also expressed at significant levels in tumour cells, impacting tumour progression. However, the comprehensive effects of ECGs on cancer prognosis and the immune microenvironment remain underexplored. This study analysed data from 33 tumour types to assess the expression, diagnostic and prognostic values of ECGs as well as gene modification landscapes. It also predicted the correlation between ECGs, the immune microenvironment and responses to immunotherapy, revealing that lower ECGs expression levels were associated with better immunotherapy responses in various cancers. Additionally, molecular docking studies simulated the interactions between TIMD4 and its sensitive drugs, facilitating targeted drug development. Finally, both in vitro and in vivo experiments confirmed that silencing TIMD4 could effectively inhibit the proliferation and invasion of renal cell carcinoma. Overall, TIMD4 can be used as an important biomarker for tumour prognosis and immunotherapy response, providing new insights into the mechanisms of tumour immune microenvironment and progression, as well as a novel therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsPhagocytosisMembrane ProteinsHumansTumor MicroenvironmentAnimalsGene Expression Regulation, NeoplasticBiomarkers, TumorPrognosisCell Line, TumorCell ProliferationMiceEfferocytosis

Stichwörter der Autor:innen

efferocytosisimmune microenvironmentimmunotherapynon‐cancer diseasespan‐cancerprognosis

Substanzen

Biomarkers, TumorMembrane Proteins

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Department of Orthopedics, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, the First Affiliated Hospital of China Medical University, Shen…
  • Department of Pathology and Pathophysiology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
  • Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, China.
  • Department of Vascular Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Hongze Li, Yu Lun

Förderung

  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Li, H., Zhang, J., Zhang, Y., Li, Z., Han, Y., & Lun, Y. (2025). A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70671

Vancouver

Li H, Zhang J, Zhang Y, Li Z, Han Y, Lun Y. A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70671

BibTeX
@article{Li2025,
  author = {Li, Hongze and Zhang, Jiaqi and Zhang, Yixiao and Li, Zixuan and Han, Yuxi and Lun, Yu},
  title = {A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70671}
}
Kostenlos starten →